NNC9204-0530 and Liraglutide combination safety, PK, and PD investigated in overweight/obese subjects
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
Abstract
A trial investigates the safety, tolerability, pharmacokinetics, and pharmacodynamics of NNC9204-0530 combined with Liraglutide in overweight or obese individuals.